Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital.

Link to article at PubMed

Related Articles

Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital.

J Clin Microbiol. 2008 Jul;46(7):2381-3

Authors: Carver PL, Lin SW, DePestel DD, Newton DW

In patients with Staphylococcus aureus bacteremia, intervention by infectious disease clinical pharmacists on the basis of the results of tests for mecA resulted in a 25.4-h reduction in the time to optimal antimicrobial therapy, from 64.7 +/- 36.8 to 39.3 +/- 15.5 h (P = 0.002), which may result in decreased mortality.

PMID: 18463221 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published. Required fields are marked *